공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

경피적 혈관 성형술(PTA) 말초 약물방출풍선(DEB) 카테터 : 의료기기 파이프라인 평가(2019년)

Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 12월 상품 코드 920867
페이지 정보 영문 157 Pages
가격
US $ 2,500 ₩ 2,798,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,596,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,394,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


경피적 혈관 성형술(PTA) 말초 약물방출풍선(DEB) 카테터 : 의료기기 파이프라인 평가(2019년) Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 12월 페이지 정보 : 영문 157 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

경피적 혈관 성형술(PTA : Percutaneous Transluminal Angioplasty) 말초 약물방출풍선(DEB : Drug Eluting Balloons) 카테터의 개발 동향을 조사했으며, 제품 개발 및 임상시험에 관한 데이터, 승인 동향, 기업 및 제품의 개요 등을 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • PTA 말초 DEB 카테터 : 개요

제3장 PTA 말초 DEB 카테터 : 개발중인 제품

  • 개발 단계별
  • Territory별
  • 절차 경로별
  • 추정 승인일별
  • 진행중인 임상시험

제4장 PTA 말초 DEB 카테터 : 개발 기업

  • 기업 : 개발 단계별
  • 제품 : 개발 단계별

제5장 PTA 말초 DEB 카테터 : 기업 및 제품의 개요

  • AnGes Inc
  • AngioCure, Inc.
  • Boston Scientific Corp
  • Cardionovum GmbH
  • Concept Medical Inc
  • Contego Medical LLC
  • eucatech AG
  • Lifetech Scientific(Shenzhen) Co Ltd
  • Lutonix Inc
  • MA Med Alliance SA
  • Medtronic plc
  • Micell Technologies Inc
  • Orchestra BioMed Inc
  • Pulsus Medical LLC
  • QT Vascular Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • SiL Vascular Ltd
  • Spectranetics Corp
  • SurModics Inc
  • Tailored Medical Devices Inc
  • TransMed7 LLC
  • Vascular Nanotransfer Technologies

제6장 PTA 말초 DEB 카테터 : 업계의 최신 동향

제7장 부록

KSA 20.01.23

List of Tables

  • Table 1: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
  • Table 2: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory
  • Table 3: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path
  • Table 4: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date
  • Table 5: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials
  • Table 6: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies - Pipeline Products by Stage of Development
  • Table 7: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
  • Table 8: AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
  • Table 10: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
  • Table 11: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: AngioCure TOP-C Smart Balloon Catheter - Product Status
  • Table 13: AngioCure TOP-C Smart Balloon Catheter - Product Description
  • Table 14: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Ranger Drug-Coated Balloon - Product Status
  • Table 16: Ranger Drug-Coated Balloon - Product Description
  • Table 17: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 18: Ranger Drug-Coated Balloon - A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis
  • Table 19: Ranger Drug-Coated Balloon - Clinical Study of the Boston Scientific Paclitaxel-coated PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter (Ranger and Ranger SL (OTW) DCB) in China
  • Table 20: Ranger Drug-Coated Balloon - JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
  • Table 21: Ranger Drug-Coated Balloon - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
  • Table 22: Ranger Drug-Coated Balloon - Prospective, Randomized, Multicenter Clinical Study of the Hemoteq Ranger Paclitaxel-coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions
  • Table 23: Ranger Drug-Coated Balloon - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
  • Table 24: Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: APERTO OTW - Product Status
  • Table 26: APERTO OTW - Product Description
  • Table 27: Cardionovum GmbH - Ongoing Clinical Trials Overview
  • Table 28: APERTO OTW - A Randomized Trial of Aperto Paclitaxel Eluting Dilatation Catheter Compared to POBA in Dialysis Fistula
  • Table 29: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: MagicTouch PTA Balloon Catheter - Product Status
  • Table 31: MagicTouch PTA Balloon Catheter - Product Description
  • Table 32: Concept Medical Inc - Ongoing Clinical Trials Overview
  • Table 33: MagicTouch PTA Balloon Catheter - A Pilot Study to Evaluate the Safety and Efficacy of MagicTouch PTA Sirolimus Coated Balloon for the Treatment of Below-the-Knee (BTK) Lesions
  • Table 34: Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Tibial Artery Drug Eluting Balloon - Product Status
  • Table 36: Tibial Artery Drug Eluting Balloon - Product Description
  • Table 37: eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Support - Product Status
  • Table 39: Support - Product Description
  • Table 40: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Status
  • Table 42: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Description
  • Table 43: Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
  • Table 44: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting Peripheral Balloon Catheter for Lesions with Femoral-popliteal Artery Stenosis or Occlusion: A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
  • Table 45: Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Lutonix 014 Drug Coated Balloon PTA Catheter - Product Status
  • Table 47: Lutonix 014 Drug Coated Balloon PTA Catheter - Product Description
  • Table 48: Lutonix 018 Drug Coated Balloon PTA Catheter - Product Status
  • Table 49: Lutonix 018 Drug Coated Balloon PTA Catheter - Product Description
  • Table 50: Lutonix Inc - Ongoing Clinical Trials Overview
  • Table 51: Lutonix 014 Drug Coated Balloon PTA Catheter - A Prospective, Multicenter, Single Arm Real-world Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon Percutaneous Transluminal Angioplasty (PTA) Catheter for Treatment of Below-the-Knee (BTK) Arteries
  • Table 52: Lutonix 014 Drug Coated Balloon PTA Catheter - A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-knee (BTK) Arteries: Lutonix BTK Trial
  • Table 53: Lutonix 014 Drug Coated Balloon PTA Catheter - Tack Optimized Balloon Angioplasty Study for Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System
  • Table 54: Lutonix 018 Drug Coated Balloon PTA Catheter - Drug Eluting Balloon for Early Fistula Failure Trial
  • Table 55: M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: SELUTION Sirolimus Coated Balloon - Product Status
  • Table 57: SELUTION Sirolimus Coated Balloon - Product Description
  • Table 58: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: IN.PACT Admiral DEB - BTK - Product Status
  • Table 60: IN.PACT Admiral DEB - BTK - Product Description

List of Figures

  • Figure 1: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
  • Figure 2: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory
  • Figure 3: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path
  • Figure 4: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date
  • Figure 5: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019" provides an overview of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Overview 10

3 Products under Development 11

  • 3.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development 11
  • 3.2 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory 12
  • 3.3 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path 13
  • 3.4 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date 14
  • 3.5 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials 15

4 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products under Development by Companies 16

  • 4.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies - Pipeline Products by Stage of Development 16
  • 4.2 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development 17

5 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies and Product Overview 19

  • 5.1 AnGes Inc Company Overview 19
    • 5.1.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 AngioCure, Inc. Company Overview 21
    • 5.2.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Boston Scientific Corp Company Overview 22
    • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Cardionovum GmbH Company Overview 27
    • 5.4.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.5 Concept Medical Inc Company Overview 31
    • 5.5.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.6 Contego Medical LLC Company Overview 34
    • 5.6.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.7 eucatech AG Company Overview 35
    • 5.7.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.8 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 36
    • 5.8.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.9 Lutonix Inc Company Overview 39
    • 5.9.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.10 M.A. Med Alliance SA Company Overview 44
    • 5.10.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.11 Medtronic plc Company Overview 45
    • 5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.12 Micell Technologies Inc Company Overview 49
    • 5.12.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.13 Orchestra BioMed Inc Company Overview 50
    • 5.13.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.14 Pulsus Medical LLC (Inactive) Company Overview 51
    • 5.14.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.15 QT Vascular Ltd Company Overview 52
    • 5.15.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.16 QualiMed Innovative Medizinprodukte GmbH Company Overview 56
    • 5.16.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.17 SiL Vascular Ltd Company Overview 57
    • 5.17.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.18 Spectranetics Corp Company Overview 58
    • 5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.19 SurModics Inc Company Overview 65
    • 5.19.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.20 Tailored Medical Devices Inc Company Overview 72
    • 5.20.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.21 TransMed7 LLC Company Overview 73
    • 5.21.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.22 Vascular Nanotransfer Technologies Company Overview 74
    • 5.22.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 74

6 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Recent Developments 76

  • 6.1 Nov 22, 2019: Medtronic receives FDA approval for IN.PACT AV DCB 76
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 76
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 79
  • 6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 80
  • 6.5 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships 80

7 Appendix 154

  • 7.1 Methodology 154
  • 7.2 About GlobalData 157
  • 7.3 Contact Us 157
  • 7.4 Disclaimer 157
Back to Top
전화 문의
F A Q